Moreover, CSO treatment did not effectively reduce HIF-1α and VEGF-A protein levels when SIRT1 was inhibited, suggesting that CSO suppressed the HIF-1α / VEGF-A pathway by upregulating SIRT1. The gene discussed is HIF1A; the disease is craniosynostosis.